Batch versus continuous
In traditional batch making, each unit operation happens in its own vessel, one after another: you blend a whole batch, stop, move it, granulate it, stop, dry it, and so on. Material waits in between, equipment sits idle, and you only learn the verdict when the lab tests the finished batch. Continuous manufacturing connects the operations into one flowing line. Powder enters one end; finished tablets emerge from the other, steadily, for as long as you choose to run.
The benefits are real: a smaller footprint, less material sitting around, and — most importantly — the ability to make a tiny amount for a trial or a huge amount for the market on the same line, just by running it longer. This is a flexibility batch processing can never offer, because in batch the equipment size dictates the batch size.
What “a batch” even means now
Continuous manufacturing forces a delicious question: if material flows nonstop, where is the batch? Regulators allow you to define it — by a time window, by a quantity, or by the material processed under one set of conditions. The batch record then captures that defined span of continuous operation. This flexibility is only safe because of what watches the line.
That something is process analytical technology (PAT) working hand in hand with QbD. Sensors measure CQAs — blend uniformity, moisture, tablet content — continuously as material flows. If a reading drifts toward the edge of the design space, the control system nudges a CPP back, or diverts the out-of-spec material away before it reaches the patient. Quality is judged in real time, not days later in a lab.
- Define the batch (e.g. “material made between 09:00 and 17:00 at the validated settings”).
- PAT sensors stream CQA data; the control system keeps CPPs inside the design space using real-time in-process control.
- Material that briefly drifts out of spec is automatically diverted, so only good product continues downstream.
- Because quality is proven continuously, the defined batch is released with far less end-product testing — sometimes approaching real-time release.
This is the through-line of the whole track. Unit operations give you the building blocks; GMP gives you the discipline and proof; QbD gives you the understanding of which knobs matter; validation proves the process is in control; and continuous manufacturing fuses all of them into a line that measures and corrects its own quality as it runs. The future of pharmaceutics is not making medicine faster — it is knowing, moment by moment, that every dose is right.